Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
If youre not deficient, routine injections are seldom necessary
Administering AOD-9604 when these receptors are already occupied or downregulated produces suboptimal results regardless of dose
Journal of Endocrinology , 2001 Demonstrated AOD9604's lipolytic properties and its selective activation of fat metabolism pathways without affecting IGF-1 levels
When to Adjust Dosing Increase dose if: After 4-6 weeks at current dose, no measurable body composition changes occur, youre tolerating current dose without side effects, youre below the upper clinical range (1 mg daily), and your physician approves escalation based on comprehensive assessment
[43] [41] During pregnancy the placenta concentrates B 12 , so that newborn infants have a higher serum concentration than their mothers